Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes
- PMID: 21937503
- DOI: 10.1136/ebm.2011.100121
Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes
Comment on
-
Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study.BJOG. 2011 Jun;118(7):880-5. doi: 10.1111/j.1471-0528.2010.02763.x. Epub 2010 Nov 18. BJOG. 2011. PMID: 21083860 Clinical Trial.
Similar articles
-
Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study.BJOG. 2011 Jun;118(7):880-5. doi: 10.1111/j.1471-0528.2010.02763.x. Epub 2010 Nov 18. BJOG. 2011. PMID: 21083860 Clinical Trial.
-
Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study.Diabet Med. 2009 Aug;26(8):798-802. doi: 10.1111/j.1464-5491.2009.02780.x. Diabet Med. 2009. PMID: 19709150
-
Metformin for gestational diabetes in routine clinical practice.Diabet Med. 2011 Sep;28(9):1082-7. doi: 10.1111/j.1464-5491.2011.03361.x. Diabet Med. 2011. PMID: 21679232
-
Fetal macrosomia and gestational diabetes: what's the problem?Obstet Gynecol. 1993 May;81(5 ( Pt 1)):775-81. Obstet Gynecol. 1993. PMID: 8469471 Review.
-
Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.Minerva Ginecol. 2008 Feb;60(1):63-75. Minerva Ginecol. 2008. PMID: 18277353 Review.
Publication types
LinkOut - more resources
Full Text Sources